2022 preview: Continuing to enhance long-term growth logic
1H23E earnings preview: All eyes on the Galaxy
FY22E preview; Bumpy recovery in 2023
–3Q preview: flattish rev/EBITDA growth
2Q23 earnings preview: NP to rise QoQ in FY23E
医药:Results preview
1H23E preview: Expecting Strategy 2.0 to gain momentum in post-pandemic periods
1H24 preview: margin weakness priced in; expect gradual ASP/margin recovery in 2H
–1H23E preview:new-car GPM could be a bottom
2022 Preview:付费阅读基本盘稳固,长期看IP矩阵工业化变现